The effect of pentoxifiline on post-injury hyperalgesia in rats and postoperative pain in patients.
Recent studies demonstrate that activation of proinflammatory cytokines following injury intensifies the process of nociception. The present investigation assessed the influence of pre-injury pentoxifiline (PTFL, a non-specific cytokine inhibitor) on the development of post-injury nociception in animals and patients. It was established that intrathecal or intraperitoneal PTFL, elevated the nociceptive threshold for mechanical stimuli in the formalin test in rats. Pre-injury PTFL also inhibited pain-related behaviour. These findings correlate with a lower TNFalpha level in the serum of animals receiving pre-injury PTFL. In clinical investigations PTFL was administered intravenously before elective cholecystectomy. Patients who received preoperative PTFL had lower opioid requirements in the early postoperative period than control. At the same time, serum levels of TNFalpha and IL6 were lower in the PTFL group. Our results confirm the hypothesis as to the possibility of modulating of nociception through preemptive administration of a cytokine inhibitor.
Wordliczek
J
J
Department of Anaesthesiology and Intensive Care, Jagiellonian University, Kraków, Poland.
Szczepanik
A M
AM
Banach
M
M
Turchan
J
J
Zembala
M
M
Siedlar
M
M
Przewlocki
R
R
Serednicki
W
W
Przewlocka
B
B
D000328:Adult; D000818:Animals; D002763:Cholecystectomy; D005557:Formaldehyde / Q000008:administration & dosage; D006801:Humans; D006930:Hyperalgesia / Q000097:blood / Q000517:prevention & control*; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007278:Injections, Spinal; D015850:Interleukin-6 / Q000097:blood; D008297:Male; D008614:Meperidine / Q000008:administration & dosage; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage; D010146:Pain / Q000097:blood / Q000188:drug therapy*; D010147:Pain Measurement; D017288:Pain Threshold / Q000187:drug effects; D010149:Postoperative Pain / Q000097:blood / Q000517:prevention & control*; D010431:Pentoxifylline / Q000627:therapeutic use*; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D051381:Rats; D017208:Rats, Wistar; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D015850:Interleukin-6; D010726:Phosphodiesterase Inhibitors; D014409:Tumor Necrosis Factor-alpha; D005557:Formaldehyde; D009020:Morphine; D008614:Meperidine; D010431:Pentoxifylline